Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
about
Delivery of sFIT-1 engineered MSCs in combination with a continuous low-dose doxorubicin treatment prevents growth of liver cancer.Tumor angiogenesis revisited: Regulators and clinical implications.Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies.Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma.Endothelial progenitor cells in multiple myeloma neovascularization: a brick to the wall.
P2860
Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antiangiogenic and Antitumor A ...... l of Hepatocellular Carcinoma.
@en
Antiangiogenic and Antitumor A ...... l of Hepatocellular Carcinoma.
@nl
type
label
Antiangiogenic and Antitumor A ...... l of Hepatocellular Carcinoma.
@en
Antiangiogenic and Antitumor A ...... l of Hepatocellular Carcinoma.
@nl
prefLabel
Antiangiogenic and Antitumor A ...... l of Hepatocellular Carcinoma.
@en
Antiangiogenic and Antitumor A ...... l of Hepatocellular Carcinoma.
@nl
P2093
P2860
P1433
P1476
Antiangiogenic and Antitumor A ...... l of Hepatocellular Carcinoma.
@en
P2093
Fumitaka Wada
Hideki Iwamoto
Hirohisa Yano
Hironori Koga
Hiroshi Masuda
Mitsuhiko Abe
Osamu Hashimoto
Takahiko Sakaue
Takato Ueno
Takuji Torimura
P2860
P304
P356
10.1016/J.NEO.2016.05.001
P577
2016-07-01T00:00:00Z